FoxWayne Enterprises Acquisition Corp. (FOXW)
Market Cap | 64.64M |
Revenue (ttm) | n/a |
Net Income (ttm) | n/a |
Shares Out | 6.30M |
EPS (ttm) | n/a |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 27 |
Last Price | $10.26 |
Previous Close | $10.45 |
Change ($) | -0.19 |
Change (%) | -1.82% |
Day's Open | - |
Day's Range | 10.25 - 10.40 |
Day's Volume | 0 |
52-Week Range | 0.00 - 10.40 |
The 2021 IPO market continued gaining momentum this past week as six IPOs and 14 SPACs raised $6.2 billion. The IPO pipeline remained active as well, with 36 new filings from IPOs and SPACs co...
NEW YORK, Jan. 22, 2021 /PRNewswire/ -- FoxWayne Enterprises Acquisition Corp. ("FoxWayne" or the "Company") announced today that has closed its initial public offering of 5,750,000 units at $...
In addition to the COVID-19 pandemic and the election of Joe Biden, one of the biggest stories of 2020 was the surge in initial public offerings (IPOs) from special-purpose acquisition compani...
FoxWayne Enterprises Acquisition, a blank check company targeting biotechnology and telemedicine in North America, filed on Wednesday with the SEC to raise up to $50 million in an initial publ...
FoxWayne Enterprises Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
About FOXW
FoxWayne Enterprises Acquisition is a newly organized blank check company incorporated as a Delaware corporation formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus our search for a target business in the biotechnology and/or telemedicine sector of the healthcare industry in North America. In particular, we intend to prioritize companies in the life sciences and pharmaceutical services sectors where our man... [Read more...]
Industry Blank Checks / SPAC | IPO Date Jan 20, 2021 |
CEO Robb Knie | Country United States |
Stock Exchange NASDAQ | Ticker Symbol FOXW |